Logo image of GNLN

GREENLANE HOLDINGS INC - A (GNLN) Stock Fundamental Analysis

NASDAQ:GNLN - Nasdaq - US3953304009 - Common Stock - Currency: USD

4.8  +0.41 (+9.34%)

Fundamental Rating

2

Taking everything into account, GNLN scores 2 out of 10 in our fundamental rating. GNLN was compared to 19 industry peers in the Distributors industry. The financial health of GNLN is average, but there are quite some concerns on its profitability. GNLN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

GNLN had negative earnings in the past year.
GNLN had a negative operating cash flow in the past year.
GNLN had negative earnings in each of the past 5 years.
In the past 5 years GNLN always reported negative operating cash flow.
GNLN Yearly Net Income VS EBIT VS OCF VS FCFGNLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

The Return On Assets of GNLN (-44.65%) is worse than 73.68% of its industry peers.
The Return On Equity of GNLN (-73.00%) is worse than 78.95% of its industry peers.
Industry RankSector Rank
ROA -44.65%
ROE -73%
ROIC N/A
ROA(3y)-75.45%
ROA(5y)-49.78%
ROE(3y)-229.47%
ROE(5y)-160.39%
ROIC(3y)N/A
ROIC(5y)N/A
GNLN Yearly ROA, ROE, ROICGNLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

GNLN's Gross Margin of 55.93% is amongst the best of the industry. GNLN outperforms 89.47% of its industry peers.
In the last couple of years the Gross Margin of GNLN has grown nicely.
GNLN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.36%
GM growth 5Y23%
GNLN Yearly Profit, Operating, Gross MarginsGNLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

GNLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
GNLN has more shares outstanding than it did 1 year ago.
GNLN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for GNLN is higher compared to a year ago.
GNLN Yearly Shares OutstandingGNLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GNLN Yearly Total Debt VS Total AssetsGNLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

GNLN has an Altman-Z score of -10.12. This is a bad value and indicates that GNLN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -10.12, GNLN is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
GNLN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.12
ROIC/WACCN/A
WACC12.04%
GNLN Yearly LT Debt VS Equity VS FCFGNLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

GNLN has a Current Ratio of 2.25. This indicates that GNLN is financially healthy and has no problem in meeting its short term obligations.
GNLN has a better Current ratio (2.25) than 68.42% of its industry peers.
A Quick Ratio of 1.29 indicates that GNLN should not have too much problems paying its short term obligations.
GNLN has a better Quick ratio (1.29) than 68.42% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.29
GNLN Yearly Current Assets VS Current LiabilitesGNLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for GNLN have decreased strongly by -10068.14% in the last year.
The Revenue for GNLN has decreased by -78.82% in the past year. This is quite bad
GNLN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -40.96% yearly.
EPS 1Y (TTM)-10068.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2442.55%
Revenue 1Y (TTM)-78.82%
Revenue growth 3Y-56.93%
Revenue growth 5Y-40.96%
Sales Q2Q%-70.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year93.46%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNLN Yearly Revenue VS EstimatesGNLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
GNLN Yearly EPS VS EstimatesGNLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GNLN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNLN Price Earnings VS Forward Price EarningsGNLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNLN Per share dataGNLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K -4K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GNLN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENLANE HOLDINGS INC - A

NASDAQ:GNLN (7/25/2025, 1:50:22 PM)

4.8

+0.41 (+9.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)07-16 2025-07-16/amc
Earnings (Next)08-12 2025-08-12
Inst Owners0.19%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap6.67M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)-4427.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.37
FCFYN/A
OCF(TTM)-7.28
OCFYN/A
SpS7.06
BVpS16.77
TBVpS16.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.65%
ROE -73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.93%
FCFM N/A
ROA(3y)-75.45%
ROA(5y)-49.78%
ROE(3y)-229.47%
ROE(5y)-160.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.36%
GM growth 5Y23%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 19.17%
Cap/Sales 1.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.29
Altman-Z -10.12
F-Score5
WACC12.04%
ROIC/WACCN/A
Cap/Depr(3y)35.35%
Cap/Depr(5y)54.18%
Cap/Sales(3y)1.8%
Cap/Sales(5y)1.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10068.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2442.55%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-78.82%
Revenue growth 3Y-56.93%
Revenue growth 5Y-40.96%
Sales Q2Q%-70.18%
Revenue Next Year93.46%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y52.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year417.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.28%
OCF growth 3YN/A
OCF growth 5YN/A